NOVACYT EO-0667
Save
–
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Medical Devices
Industry
Novacyt S. A., together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Similar securities
Based on sector and market capitalization
Report issue